HanchorBio Statistics

Total Valuation

HanchorBio has a market cap or net worth of TWD 10.18 billion. The enterprise value is 9.37 billion.

Market Cap	10.18B
Enterprise Value	9.37B

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

HanchorBio has 130.01 million shares outstanding. The number of shares has increased by 115.73% in one year.

Current Share Class	130.01M
Shares Outstanding	130.01M
Shares Change (YoY)	+115.73%
Shares Change (QoQ)	+3.23%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	32.60
PB Ratio	9.55
P/TBV Ratio	13.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-18.83
EV / Sales	30.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-30.41

Financial Position

The company has a current ratio of 4.74, with a Debt / Equity ratio of 0.10.

Current Ratio	4.74
Quick Ratio	4.68
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-0.33
Interest Coverage	-79.20

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-33.17%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, HanchorBio has paid 33.29 million in taxes.

Income Tax	33.29M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	73.45
200-Day Moving Average	n/a
Relative Strength Index (RSI)	63.50
Average Volume (20 Days)	437,611

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HanchorBio had revenue of TWD 312.22 million and -497.62 million in losses. Loss per share was -4.43.

Revenue	312.22M
Gross Profit	312.22M
Operating Income	-353.72M
Pretax Income	-464.33M
Net Income	-497.62M
EBITDA	-328.27M
EBIT	-353.72M
Loss Per Share	-4.43

Full Income Statement

Balance Sheet

The company has 1.22 billion in cash and 102.29 million in debt, giving a net cash position of 1.11 billion or 8.57 per share.

Cash & Cash Equivalents	1.22B
Total Debt	102.29M
Net Cash	1.11B
Net Cash Per Share	8.57
Equity (Book Value)	1.07B
Book Value Per Share	5.86
Working Capital	977.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -293.33 million and capital expenditures -14.76 million, giving a free cash flow of -308.09 million.

Operating Cash Flow	-293.33M
Capital Expenditures	-14.76M
Free Cash Flow	-308.09M
FCF Per Share	-2.37

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -113.29% and -159.38%.

Gross Margin	100.00%
Operating Margin	-113.29%
Pretax Margin	-148.72%
Profit Margin	-159.38%
EBITDA Margin	-105.14%
EBIT Margin	-113.29%
FCF Margin	n/a

Dividends & Yields

HanchorBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-115.73%
Shareholder Yield	-115.73%
Earnings Yield	-4.89%
FCF Yield	-3.03%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HanchorBio has an Altman Z-Score of 17.56 and a Piotroski F-Score of 2.

Altman Z-Score	17.56
Piotroski F-Score	2